Aptima Assay was approved for use when Pap smear finds cells of undetermined significance and as an adjunct to Pap testing. FDA approved Gen-Probe’s Aptima HPV assay for use on the firm’s automated ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA has approved Gen-Probe’s Aptima HPV assay, an amplified nucleic acid test that detects 14 high-risk strains of human papillomavirus (HPV) that are associated with cervical cancer and ...

“Hologic has been at the forefront of cervical cancer screening for decades, and the additional indication of the Aptima HPV Assay reflects our ongoing commitment to advancing women’s health through ...

Screening for cervical cancer is critically important to women’s health. In the United States, it is estimated that in 2026, approximately 13,490 new cases of invasive cervical cancer will be ...

MARLBOROUGH, Mass., February 04, 2026--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening.

Hologic Inc, a global company offering a broad portfolio for cervical cancer screening, announced that its Aptima HPV assay received US Food and Drug Administration approval for clinician-collected ...